Mitofusin 2 Inhibits Angiotensin II-Induced Myocardial Hypertrophy

Abstract

Background and Objectives: Myocardial hypertrophy is a common clinical finding leading to heart failure and sudden death. Mitofusin 2 (Mfn2), a hyperplasia suppressor protein, is downregulated in hypertrophic heart. This study examined the role of Mfn2 in myocardial hypertrophy and its potential signal pathway. Methods and Results: In in vitro studies, neonatal cardiac myocytes were isolated and cultured. Incubation of cultured cardiomycytes with angiotensin II (Ang II) inhibited gene expression of Mfn2; induced cell hypertrophy and protein synthesis; and activated protein kinase Akt. Pretreatment of cells with AdMfn2—a replication-deficient adenoviral vector encoding rat Mfn2 gene—upregulated Mfn2 expression and subsequently attenuated Ang II-induced cell hypertrophy; protein synthesis; and Akt activation. In in vivo studies, direct gene delivery of AdMfn2 into myocardium decreased the infusion of Ang II-induced atrial natriuretic factor (ANF, a hypertrophic marker) expression and cardiomyocyte cross-sectional area. Consistently, upregulation of Mfn2 in myocardium decreased the thicknesses of anterior and posterior walls of left ventricle (LV) and the ratio of LV mass/body weight in Ang II-treated rats. Of note, AdGFP (control for AdMfn2) did not affect the effects of Ang II in vitro or in vivo. Conclusions: Upregulation of Mfn2 inhibits Ang II-induced myocardial hypertrophy. In this process, inhibition of Akt activation seems to play a significant role. These findings indicate Mfn2 is a critical protein in modulating myocyte hypertrophy.

Keywords

cardiac remodeling myocyte hypertrophy mitofusin 2

References

Venkatachalam K. , Venkatesan B. , Valente AJ , et al. WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death . J Biol Chem. 2009; 284(21):14414-14427.

Espira L. , Czubryt MP Emerging concepts in cardiac matrix biology. Can J Physiol Pharmacol. 2009;87(12):996-1008.

Oka T. , Komuro I. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure. Circ J. 2008; 72(supplA):A13-A16.

Schnee JM , Hsueh WA Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res. 2000;46(2):264-268.

Kawano H. , Do YS , Kawano Y. , et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation. 2000;101(10):1130-1137.

Aoki H. , Richmond M. , Izumo S. , Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem J. 2000;347(pt1): 275-284.

Bach D. , Pich S. , Soriano FX , et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003;278(19):17190-17197.

Chen KH , Guo X. , Ma D. , et al. Dysregulation of HSG triggers vascular proliferative disorders . Nat Cell Biol. 2004;6(9):872-883.

Fang L. , Moore XL , Gao XM , Dart AM , Lim YL , Du XJ Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci. 2007;80(23):2154-2160.

10.

Chen CL , Shen T. , Zheng M. , Guo YH , Zhu XJ , Chen GH Inhibition of cardiac hypertrophy by mitofusin 2 in neonatal rat cardiomyocytes . Beijing Da Xue Xue Bao. 2008;40(5):528-532.

11.

Stewart JA Jr , Cashatt DO , Borck AC , Brown JE , Carver WE 17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. J Mol Cell Cardiol. 2006;41(1):97-107.

12.

Cheng CM , Hong HJ , Liu JC , et al. Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol Pharmacol. 2003;63(5):1002-1011.

13.

Ito H. , Hirata Y. , Hiroe M. , et al. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991;69(1):209-215.

14.

Guo YH , Chen K. , Gao W. , et al. Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun. 2007;363(2):411-417.

15.

Davis J. , Westfall MV , Townsend D. , et al. Designing heart performance by gene transfer. Physiol Rev. 2008;88(4):1567-1651.

16.

Szatkowski ML , Westfall MV , Gomez CA , et al. In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J Clin Invest. 2001;107(2):191-198.

17.

Wang DH , Qiu J. , Hu Z. , Du Y. Regulation of type 1 angiotensin II receptor in adrenal gland: role of alpha1-adrenoreceptor . Hypertension. 1997;30(3pt1):345-350.

18.

Parkington HC , Dodd J. , Luff SE , et al. Selective increase in renal arcuate innervation density and neurogenic constriction in chronic angiotensin II-infused rats. Hypertension. 2004;43(3):643-648.

19.

Busk PK , Bartkova J. , Strom CC , et al. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res. 2002 ;56(1):64-75.

20.

Ai D. , Pang W. , Li N. , et al. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A. 2009;106(2):564-569.

21.

Wang J. , Xu N. , Feng X. , et al. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res. 2005 ;97(8):821-828.

22.

Shen T. , Zheng M. , Cao C. , et al. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem. 2007;282(32):23354-23361.

23.

Liu N. , Chen G. , Wang X. , et al. Effects of certain vasoactive peptides on pathogenesis of vascular restenosis. Chin Med Sci J. 2003;18(1):1-8.

24.

Chen G. , Liu N. , Zhou A. , Tang C. , Ma D. , Tang J. The role of hypertension-related gene in aortic vascular smooth muscle cells from mice and rats. Chin Med J (Engl). 2001;114(8): 833-836.

25.

Ahmad S. , Cesana F. , Lamperti E. , Gavras H. , Yu J. Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. Am J Hypertens. 2009;22(12):1320-1325.

26.

Zou Y. , Komuro I. , Yamazaki T. , et al. Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts. Circ Res. 1998;82(3):337-345.

27.

Schorb W. , Booz GW , Dostal DE , Conrad KM , Chang KC , Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts . Circ Res. 1993;72(6):1245-1254.

28.

Schorb W. , Peeler TC , Madigan NN , Conrad KM , Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem. 1994 ;269(30):19626-19632.

29.

Cobb MH , Boulton TG , Robbins DJ Extracellular signal-regulated kinases: ERKs in progress. Cell Regul. 1991;2(12): 965-978.

30.

Pages G. , Lenormand P. , L’Allemain G. , Chambard JC , Meloche S. , Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993 ;90(18):8319-8323.

31.

Guo X. , Chen KH , Guo Y. , Liao H. , Tang J. , Xiao RP Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 2007;101(11):1113-1122.